Indeed, in both 786-O cells (Fig 4D) and primary human RCC cells (Fig 4E), WYE-687 (100 nM, 12 hours) treatment induced significant downregulation of HIF-1α and HIF-2α. Here, HIF1A is linked to renal cell carcinoma.